Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2026-04-10 17:29:29 ET · period of report 2026-04-08 · accession 0001628280-26-024767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 17:29 | 2026-04-08 | BLFS | Mathew Aby J. | EVP, CSO | F - Tax | $19.27 | -515 | 390.2K | -0.1% | -$9,924 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-08 | F | D | 515 | $19.27 | 390,167 | D | — | — | (F1) Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |